Skip to main content
OpenTrials

Clinical trial condition

Lupus Erythematosus, Systemic

Explore clinical trials studying Lupus Erythematosus, Systemic. Study availability and eligibility vary by location and protocol.

139 public trials 43 recruiting studies
Refine in advanced search Browse all conditions

Lupus Erythematosus, Systemic trial results

Recruiting

VIBRANT: VIB4920 for Active Lupus Nephritis

NCT05201469

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +11 more
Locations
  • University of California San Diego School of Medicine: Division of Rheumatology, Allergy and Immunology La Jolla, California, United States
  • UCLA Medical Center: Division of Rheumatology Los Angeles, California, United States
  • of California, Irvine School of Medicine Division of Rheumatology Orange, California, United States
  • University of California San Francisco School of Medicine: Lupus Clinic and Rheumatology Clinical Research Center San Francisco, California, United States
View all 17 locations
View Trial Details
Recruiting

The Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) Study

NCT05538208

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +11 more
Locations
  • University of California, San Francisco San Francisco, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Emory Children's Center Atlanta, Georgia, United States
  • Ann & Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States
View all 19 locations
View Trial Details
Recruiting

Phase III Extension Study of Efficacy and Safety of Ianalumab With or Without Study Treatment Withdrawal in Participants With Lupus Nephritis (SIRIUS-LN Extension)

NCT06711887

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +11 more
Locations
  • Circuit Clinical Orchard Park, New York, United States
  • Novartis Investigative Site Belo Horizonte, Minas Gerais, Brazil
  • Novartis Investigative Site Santo André, São Paulo, Brazil
  • Novartis Investigative Site Guangzhou, Guangdong, China
View all 49 locations
View Trial Details
Recruiting

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric Participants

NCT05039619

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +11 more
Locations
  • Loma Linda University health Loma Linda, California, United States
  • UCSF Benioff Childrens Hospital San Francisco, California, United States
  • Children's Hospital Colorado, Anchutz Medical Campus Aurora, Colorado, United States
  • Emory Children's Center Atlanta, Georgia, United States
View all 43 locations
View Trial Details
Recruiting

PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis

NCT07611214

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +11 more
Locations
  • Purushotham & Akther Kotha MD, Inc. La Mesa, California, United States
  • Valerius Medical Group & Research Center of Greater Long Beach, Inc. Los Alamitos, California, United States
  • Swati Shah MD Rheumatology, LLC Jacksonville, Florida, United States
  • CTR Oakwater Orlando, Florida, United States
View all 27 locations
View Trial Details

Related conditions